Advanced Practice Midwife in Hendersonville, NC Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Ms. Catherine Tambroni-parker, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 50 Hospital Dr, Suite 4a, Hendersonville, NC 28792 Phone: 828-650-8077    Fax: 828-651-0194

Mrs. Victoria Ann Delestowicz, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 50 Hospital Dr Ste 4a, Hendersonville, NC 28792 Phone: 828-650-8077    Fax: 828-651-0194

Deborah S Wright, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 50 Hospital Dr, Suite 5a, Hendersonville, NC 28792 Phone: 828-650-8077    Fax: 828-651-0194

Cynthia Taylor Noland, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 50 Hospital Dr Ste 4a, Hendersonville, NC 28792 Phone: 828-650-8077    Fax: 828-651-0194

News Archive

Data on UCB's anti-epileptic drugs to be presented at AES annual meeting

New data on UCB's anti-epileptic drug (AED) Vimpat (lacosamide) C-V will be presented at the 64th annual meeting of the American Epilepsy Society (AES), taking place at the San Antonio Convention Center in San Antonio, Texas from December 3 to 7, 2010. Data will also be presented on Keppra XR and the investigative epilepsy therapy, brivaracetam.

Study aims to improve early detection of atrial fibrillation

A new clinical study on the early detection of atrial fibrillation at home is starting at the German Centre for Cardiovascular Research. This cardiac arrhythmia is responsible for a quarter of all strokes and yet the risk of patients with atrial fibrillation having a stroke can be reduced by 70 percent if they take anticoagulants early enough.

Scientists discover cell responsible for triggering chronic, low-level inflammation in fat tissue

When fat cells in the body are stuffed with excess fat, the surrounding tissue becomes inflamed. That chronic, low-level inflammation is one of the driving factors behind many of the diseases associated with obesity.

Precision Therapeutics' ChemoFx test feasible in cervical cancer

Precision Therapeutics announces the acceptance of a new abstract on the ChemoFx® in vitro drug response marker for publication in conjunction with the American Society of Clinical Oncology (ASCO) 2012 Annual Meeting.

Read more Medical News

› Verified 9 days ago